| 1. |  | Digital Health | Commercial | VIEW |
| 2. |  A.N.B. Laboratories Bangkok, Thailand | CDMO | Commercial | VIEW |
| 3. |  AGS Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 4. |  Ajanta Pharma Mumbai, India | Pharma | Commercial | VIEW |
| 5. |  Alexion Pharmaceuticals Boston, USA | Pharma | Commercial | VIEW |
| 6. |  Alkeus Pharmaceuticals Cambridge, USA | Biotech | Phase 3 | VIEW |
| 7. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 8. |  AskGene Camarillo, California, United States | Biotech | Phase 3 | VIEW |
| 9. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 10. |  | MedTech | Commercial | VIEW |
| 11. |  BRIM Biotechnology, Inc. Taipei, Taiwan | Biotech | Phase 3 | VIEW |
| 12. |  Bausch Health Laval, Canada | Pharma | Commercial | VIEW |
| 13. |  | Pharma | Discovery through Commercial | VIEW |
| 14. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 15. |  BlueRock Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 16. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 17. |  CDR-Life Schlieren, Zurich, Switzerland | Biotech | Phase 1 | VIEW |
| 18. |  Canyon Labs Bluffdale, Utah, USA | CRO | Commercial | VIEW |
| 19. |  Cell-Tx Seoul, South Korea | Biotech | Preclinical | VIEW |
| 20. |  Celltrion Incheon, South Korea | Pharma | Commercial | VIEW |
| 21. |  Chengdu Kanghong Pharmaceutical Group Chengdu, China | Biotech | Commercial | VIEW |
| 22. |  | CRO | Commercial | VIEW |
| 23. |  ClinTrialSolutions, LLC Roswell, Georgia, USA | CRO | Commercial | VIEW |
| 24. |  DifGen Pharmaceuticals Miramar, USA | Biotech | Commercial | VIEW |
| 25. |  Emsere Leiden, Netherlands | CRO | Commercial | VIEW |
| 26. |  Esteve Healthcare Barcelona, Spain | Pharma | Commercial | VIEW |
| 27. |  Eurofins Consumer Product Testing (CPT) Luxembourg City, Luxembourg (Global); Norwood, MA (US) | CRO | Commercial | VIEW |
| 28. |  Formycon AG Planegg-Martinsried, Germany | Biotech | Commercial | VIEW |
| 29. |  GenAns Biotech Beijing, China | Biotech | Preclinical | VIEW |
| 30. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 31. |  Grand Pharmaceutical Group Wuhan, China | Pharma | Commercial | VIEW |
| 32. |  HKSH Medical Group Happy Valley, Hong Kong | CRO | Commercial | VIEW |
| 33. |  | Biotech | Phase 3 | VIEW |
| 34. |  HealthGraph Bangalore, India | Digital Health | Commercial | VIEW |
| 35. |  Hexal AG Holzkirchen, Germany | Pharma | Commercial | VIEW |
| 36. |  Holostem S.r.l. Modena, Italy | Biotech | Commercial | VIEW |
| 37. |  Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China | Biotech | Phase 2 | VIEW |
| 38. |  Hudson Pharmaceuticals Ltd. Dhaka, Bangladesh | Biotech | Commercial | VIEW |
| 39. |  Huons Co., Ltd. Seongnam, South Korea | Biotech | Commercial | VIEW |
| 40. |  Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland | Pharma | Commercial|Phase 1-3 | VIEW |
| 41. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 42. |  Kowa Company, Ltd. Nagoya, Japan | Pharma | Commercial | VIEW |
| 43. |  Laboratoires Théa Clermont-Ferrand, France | Pharma | Commercial | VIEW |
| 44. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 45. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 46. |  NAMSA Northwood, Ohio, USA | CRO | Commercial | VIEW |
| 47. |  Nanoscope Therapeutics Dallas, USA | Biotech | Commercial | VIEW |
| 48. |  New World Medical Rancho Cucamonga, USA | MedTech | Commercial | VIEW |
| 49. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 50. |  Noveome Biotherapeutics Pittsburgh, Pennsylvania, USA | Biotech | Phase 1-2 | VIEW |
| 51. |  OPIS (a KCR Group Company) Desio (Milan), Italy | CRO | Commercial | VIEW |
| 52. |  Ocular Therapeutix, Inc. Bedford, Massachusetts, USA | Biotech | Commercial | VIEW |
| 53. |  PharmaResearch Co., Ltd. Seongnam-si, South Korea | Biotech | Commercial | VIEW |
| 54. |  RAFARM S.A. Paiania, Greece | CDMO | Commercial | VIEW |
| 55. |  Radiant Pharmaceuticals Limited Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 56. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 57. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 58. |  | Pharma | Commercial | VIEW |
| 59. |  SIFI Aci Sant'Antonio (Catania), Italy | Biotech | Commercial | VIEW |
| 60. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 61. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 62. |  Sandoz Group AG Basel, Switzerland | Pharma | Commercial | VIEW |
| 63. |  Siegfried Holding AG Zofingen, Switzerland | CDMO | Commercial | VIEW |
| 64. |  SinSa Labs Lidingö, Sweden | Biotech | Preclinical | VIEW |
| 65. |  Stoke Therapeutics Bedford, USA (Moving to Waltham, MA in late 2026) | Biotech | Phase 3 | VIEW |
| 66. |  TRB Pharma Campinas, Brazil | Biotech | Commercial | VIEW |
| 67. |  TechnoPhage Lisbon, Portugal | Biotech | Phase 1/IIa through Phase 3 in development | VIEW |
| 68. |  Tecnoquímicas S.A. Cali, Colombia | CDMO | Commercial | VIEW |
| 69. |  Théa Open Innovation Clermont-Ferrand, France | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 70. |  | CRO | Commercial | VIEW |
| 71. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |
| 72. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |